Publication:
The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children With Overactive Bladder

Placeholder

Departments

School / College / Institute

Program

KU-Authors

KU Authors

Co-Authors

Altuntas, Turker
Sekerci, Cagri Akin
Basok, Banu Isbilen
Fidan, Mesut
Ozkan, Onur Can
Yucel, Selcuk
Cam, Kamil
Tarcan, Tufan

Publication Date

Language

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Aim Recent studies have highlighted the relationship between biomarkers and overactive bladder (OAB). Detrusor overactivity has been linked to increased Adenosine Triphosphate (ATP) secretion from urothelium and cholinergic nerve endings. This study aimed to evaluate urinary ATP as a diagnostic and follow-up biomarker for children with OAB, previously studied only in adults and children with neurogenic bladders.Materials and Methods Fifty-eight children with OAB and 28 healthy controls were prospectively included. Two midstream urine samples were collected from the OAB group: one pretreatment and one at the first month of anticholinergic treatment. Urine samples were centrifuged, stored at -80 degrees C, and ATP levels were measured via ELISA. Comparisons were made between the groups and pre-/posttreatment ATP levels in the OAB group. Correlation analysis was conducted between ATP levels and lower urinary system (LUS) parameters.Results Of the OAB group, 29 (50%) were male, with a median age of 7 years (5-15), compared to 10 years (5-16) in controls. Median urinary ATP was significantly higher in the OAB group [12.15 (2.48-170.62) ng/mg Cr] than in controls [9.92 (3.09-29.95); p = 0.04]. No significant difference was found between pre- and posttreatment ATP levels in the OAB group (p = 0.84), nor was there a correlation between ATP levels and LUS parameters.Conclusion This prospective trial is the first to document that urinary ATP levels are higher in children with OAB. Consequently, urinary ATP could serve as a diagnostic biomarker for OAB in children. Larger studies with varying symptom levels and invasive urodynamic testing are needed to further evaluate its clinical utility, particularly in monitoring treatment response.

Source

Publisher

WILEY

Subject

Urology & Nephrology

Citation

Has Part

Source

Neurourology and Urodynamics

Book Series Title

Edition

DOI

10.1002/nau.70168

item.page.datauri

Link

Rights

CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)

Copyrights Note

Creative Commons license

Except where otherwised noted, this item's license is described as CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details